MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Journal of the European Academy of Dermatology and Venereology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

401 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
401 works in the cohort · of 4,299,418page 2 of 9

Labels cover 2 of 401 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 401 of 401 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (<scp>UNCOVER</scp>‐1, <scp>UNCOVER</scp>‐2 and <scp>UNCOVER</scp>‐3)
Alan Menter, Richard B. Warren, Richard G. Langley, Joseph F. Merola, Lisa Kerr, Ellen B. Dennehy +4 more
2017· article· en· Journal of the European Academy of Dermatology and Venereology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
74
citations
affunlabeled
Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild‐to‐moderate toenail onychomycosis: results from three randomized studies using double‐blind vehicle‐controlled and open‐label active‐controlled designs
Boni E. Elewski, Mahmoud A. Ghannoum, P. Mayser, Aditya K. Gupta, Hans Christian Körting, R.J. Shouey +10 more
2011· article· en· Journal of the European Academy of Dermatology and Venereology· Medicine
machine prediction:candidate · noneconsensus · none
72
citations
affunlabeled
Management and treatment of chronic urticaria (<scp>CU</scp>)
Marcus Maurer, Martin K. Church, Margarida Gonçalo, Gordon Sussman, Mario Sánchez‐Borges
2015· article· en· Journal of the European Academy of Dermatology and Venereology· Medicine
machine prediction:candidate · noneconsensus · none
71
citations
affunlabeled
Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open‐label extension trial of the interleukin‐12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis
Richard G. Langley, Kim Papp, Alice B. Gottlieb, Gerald G. Krueger, Kenneth B. Gordon, David A. Williams +3 more
2012· article· en· Journal of the European Academy of Dermatology and Venereology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
69
citations
affno abstractunlabeled
Redefining treatment options in chronic hand eczema (CHE)
Robert Bissonnette, Thomas L. Diepgen, Peter Elsner, John English, Robin Graham‐Brown, Bernhard Homey +4 more
2010· review· en· Journal of the European Academy of Dermatology and Venereology· Medicine
machine prediction:candidate · noneconsensus · none
65
citations
affunlabeled
Fragility of epidermis in newborns, children and adolescents
Ulrike Blume‐Peytavi, Jerry Tan, Dominique Tennstedt, F. Boralévi, Gabriella Fabbrocini, Antonio Torrelo +24 more
2016· review· en· Journal of the European Academy of Dermatology and Venereology· Health Professions
machine prediction:candidate · noneconsensus · none
61
citations
affunlabeled
Nondermatophyte mould onychomycosis
Aditya K. Gupta, Richard C. Summerbell, M. Venkataraman, Emma M. Quinlan
2021· review· en· Journal of the European Academy of Dermatology and Venereology· Medicine
machine prediction:candidate · noneconsensus · none
55
citations
affunlabeled
The specific dermatoses of pregnancy: a re‐appraisal
SI Al‐Fares, Samantha Vaughan Jones, MM Black
2001· review· en· Journal of the European Academy of Dermatology and Venereology· Medicine
machine prediction:candidate · noneconsensus · none
55
citations
affunlabeled
Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial
Andreas Wollenberg, Takeshi Nakahara, Catherine Maari, Ketty Peris, Peter Lio, Matthias Augustin +9 more
2021· article· en· Journal of the European Academy of Dermatology and Venereology· Medicine
machine prediction:candidate · noneconsensus · none
53
citations
affunlabeled
Development of an atrophic acne scar risk assessment tool
Jerry Tan, Diane Thiboutot, Harald Gollnick, Sewon Kang, Alison Layton, Vicente Torres +2 more
2017· review· en· Journal of the European Academy of Dermatology and Venereology· Medicine
machine prediction:candidate · noneconsensus · none
51
citations

How this was built: Screen · Findings · About